Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Disease

Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Diseases with Jonathan Rigby Revolo Biotherapeutics


An Empowered Patient Podcast at Medical and Pharma Insider


Jonathan Rigby, CEO of Revolo Biotherapeutics discusses with Karen Jagoda the company's revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system.


A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid arthritis, uveitis, eosinophilic esophagitis and allergic diseases.


Revolo Biotherapeutics website: RevoloBio.com


Podcast: http://empoweredpatientradio.com/resetting-the-immune-system-to-drive-long-term-disease-remission-in-autoimmune-and-allergic-diseases-with-jonathan-rigby-revolo-biotherapeutics


Transcript of Podcast: http://empoweredpatientradio.com/resetting-the-immune-system-to-drive-long-term-disease-remission-in-autoimmune-and-allergic-diseases-with-jonathan-rigby-revolo-biotherapeutics-transcript


Empowered Patient Website: https://empoweredpatientradio.com


Medical and Pharma Insider Website: https://fcglobalstrategies.com